| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $75.1M | +160.6% |
| R&D Expense | $186.8M | +11.7% |
| SG&A Expense | $83.2M | +14.5% |
| Operating Income | -$217.1M | +31.0% |
| Pre-tax Income | -$177.6M | +11.4% |
| Income Tax | -$31.2M | +16.9% |
| Net Income | -$146.4M | +10.1% |
| EPS (Basic) | -$0.49 | +10.9% |
| EPS (Diluted) | -$0.49 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $128.5M | -17.8% |
| Accounts Receivable | $39.4M | +23.2% |
| Inventory | $6.3M | — |
| Current Assets | $728.2M | -3.1% |
| Total Assets | $1.36B | -0.3% |
| Current Liabilities | $64.3M | -16.1% |
| Total Liabilities | $390.0M | +28.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$131.3M | -20.9% |
| Capital Expenditures | $42.8M | -45.4% |
| Investing Cash Flow | $87.8M | -27.7% |
| Financing Cash Flow | $14.1M | +10.3% |
| Free Cash Flow | -$174.1M | +6.9% |
| +10.9% |
| Stockholders' Equity |
| $966.9M |
| -8.4% |